Product Code: ETC7547102 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 | |
The India MRSA drugs market import shipment demonstrated a strong growth trend with a CAGR of 8.2% from 2020 to 2024. However, there was a slight decline in growth rate between 2023 and 2024, indicating a temporary slowdown. Overall, the market expanded steadily with some fluctuations in momentum towards the end of the period.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India MRSA Drugs Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India MRSA Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 India MRSA Drugs Market - Industry Life Cycle |
3.4 India MRSA Drugs Market - Porter's Five Forces |
3.5 India MRSA Drugs Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 India MRSA Drugs Market Revenues & Volume Share, By Administration, 2021 & 2031F |
3.7 India MRSA Drugs Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 India MRSA Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of MRSA infections in India |
4.2.2 Growing awareness about the importance of early detection and treatment of MRSA |
4.2.3 Technological advancements in drug development for MRSA |
4.3 Market Restraints |
4.3.1 High cost associated with MRSA drugs |
4.3.2 Limited accessibility to healthcare facilities in rural areas |
4.3.3 Increasing competition from generic drug manufacturers |
5 India MRSA Drugs Market Trends |
6 India MRSA Drugs Market, By Types |
6.1 India MRSA Drugs Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 India MRSA Drugs Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 India MRSA Drugs Market Revenues & Volume, By Lipopeptide, 2021- 2031F |
6.1.4 India MRSA Drugs Market Revenues & Volume, By Oxazolidinone, 2021- 2031F |
6.1.5 India MRSA Drugs Market Revenues & Volume, By Tetracycline, 2021- 2031F |
6.1.6 India MRSA Drugs Market Revenues & Volume, By Cephalosporin, 2021- 2031F |
6.1.7 India MRSA Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.2 India MRSA Drugs Market, By Administration |
6.2.1 Overview and Analysis |
6.2.2 India MRSA Drugs Market Revenues & Volume, By Oral, 2021- 2031F |
6.2.3 India MRSA Drugs Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.3 India MRSA Drugs Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 India MRSA Drugs Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.3.3 India MRSA Drugs Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.3.4 India MRSA Drugs Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
7 India MRSA Drugs Market Import-Export Trade Statistics |
7.1 India MRSA Drugs Market Export to Major Countries |
7.2 India MRSA Drugs Market Imports from Major Countries |
8 India MRSA Drugs Market Key Performance Indicators |
8.1 Number of MRSA cases diagnosed annually |
8.2 Adoption rate of new MRSA drug treatments |
8.3 Research and development investments in MRSA drug development |
9 India MRSA Drugs Market - Opportunity Assessment |
9.1 India MRSA Drugs Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 India MRSA Drugs Market Opportunity Assessment, By Administration, 2021 & 2031F |
9.3 India MRSA Drugs Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 India MRSA Drugs Market - Competitive Landscape |
10.1 India MRSA Drugs Market Revenue Share, By Companies, 2024 |
10.2 India MRSA Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |